# NOVA Laboratory — continuation checkpoint (13 November 2026)

> This note anchors the ongoing work after the ChatGPT project conversation **«مواصلة الدردشة»**. It is a continuity reference, NOT a release approval, clinical certification, or claim of completed integration. Never use it to overwrite newer verified code or evidence.

## Scope and strict decisions
- Only NOVA Hospital laboratory is in scope. Keep the existing NOVA RTL interfaces and existing order/result/save/print flow. Do not rebuild the laboratory from scratch.
- Replace the old NOVA laboratory *catalogue*, not historical NOVA patient/order records, with **Royal Lab’s own 367 tests / 1,245 analytes**. Avoid old-NOVA name matching; use persistent source IDs and source-verified relationships.
- Preserve original clinical analyte titles, result types, active flags, dropdown option IDs and labels, unit IDs, reference ranges, source evidence and department ordering. Do not fabricate missing dropdowns, units, ranges, methods, or normal values from online examples.
- Do not migrate Royal Lab patients, results, old orders or prices.
- Do not expose Royal Lab technical source IDs/codes in end-user NOVA labels; keep them internally for audit and stable mapping.
- Do not alter NOVA pharmacy, its functioning thermal receipt printing, sales, stock, returns, other hospital modules or accepted lab A4 print behavior. Lab A4 should be portrait with patient header and results on one coherent report, without 'partial report' boilerplate.
- Make reversible/idempotent catalogue installation; no destructive production changes without verified preflight/backups/rollback.
- User preference: finish practical fixes in large, carefully tested batches; avoid many low-content progress reports, repeated reuploads, or repetitive questions.

## Repositories / reference points
- NOVA repo: `megdad234/nova-hospital-test`
- NOVA feature branch: `feature/royallab-full-migration-20261111`; keep `main` untouched.
- Original source: private `megdad234/Royallab-Recovery`, branch `recovered-results`, backed by original `RoyalLabDB.bak`.
- Bundled NOVA source: `hospital/royallab_source/nova_lab_library.json` (original user-supplied ~3 MB library available in repository; do not demand reupload without actual necessity).
- Existing design/validation evidence: `docs/ROYALLAB_NOVA_MIGRATION_MASTER_PLAN.md`, `docs/ROYALLAB_REAL_DATA_VALIDATION_2026-11-11.md`.
- Useful implementation: `hospital/royallab_catalog_audit.py`, `hospital/royallab_native_catalog_store.py`, `hospital/royallab_field_adapter.py`, `hospital/royallab_clinical_template_review.py`, `hospital/royallab_missing_test_review_templates.py` and `tests/test_royallab_*.py`.
- Last inspected pre-checkpoint commit: `555b57902fdfada93039d9eae78f19de44766f48` (12 November 2026); read-only audit workflow 43313804043 completed successfully. This is not proof of an accepted or installed production Windows setup.

## Source evidence already verified
- 367 source tests, 1,245 analytes, original 1,493 result formats.
- 10,108 linked dropdown options; **2,551 unlinked choices** preserved separately (not blindly attached). Source integrity records include 64 analytes referring to missing parent test IDs; source-verified numeric format subtype mapping is implemented separately.
- Source recovery `output/nova_library/validation.json` reports 63 tests with no candidate analytes, 36 with partial coverage, and 87 requiring review under the previous staging rules. Do not confuse audit flags with current runtime-blocked count; re-run `python -m hospital.royallab_catalog_audit` on HEAD for current counts.
- Follow-up source-only audit 13 Nov: `output/nova_library/test_coverage_report.json` contains **57 tests with zero source analytes**; the source recovery has **66 historical per-test result-table CSV files** named `dbo__Test_<ID>.csv`, **none for those 57 IDs**. Historical result tables do exist for some partially represented forms (examples: test 7 Urine; 8 Stool; 13 malaria; 21 CBC; 60 HbA1c). Thus do not claim historical result tables can reconstruct missing tests when no matching table exists. Read *headers / IDs only* if studying evidence; never copy patient result rows into NOVA or public repo.
- Legacy archived `dbo__Test_60.csv` includes an HbA1c result-column identifier even though original HbA1c analyte fields are inactive. This **does not authorize reactivating** them. The current independent clinical review/test guard enforces inactive source fields stay review-only until local documented approval.
- Cases with absent source evidence must remain explicitly reviewable, not silently guessed. Any kit-specific selectable choices must come from the actual local assay and verified source or an independent clinical method review, not generic internet lists.

## Next implementation priorities (not claims of completed work)
1. Re-run current branch's source audit and classify runtime-blocked tests by exact cause, separating non-laboratory services, inactive/blank separators, true missing analyte/format/option links, unsupported field types, and missing local method evidence.
2. For partial tests with `dbo__Test_<ID>` tables, compare **schema-only** `AnalyteResult_<analyteID>_<resultformatID>` headers to source `dbo__Analyte.csv` / `dbo__ResultFormat.csv`. Propose only exact-ID source links; do not infer by similar name or copy results.
3. Retain source-proven dropdowns. For genuinely missing closed-format links/options, show a safe review/draft path instead of fabricated choices; enforce review by independently authorized clinical staff before clinical activation.
4. End-to-end verify NOVA order picker → typed result input → save/reopen/edit → A4 print for CBC, urine, stool, malaria, culture/sensitivity, plus incomplete-test behavior and service exclusions. Preserve pharmacy unchanged.
5. Re-run Windows Actions build and tests; inspect actual installer contents and installed workflow. Hand over `Setup.exe` only after real verified build and acceptance evidence. No premature "all done" assertion.
